EcoDrugPlus

Retinoid X Receptor Alpha

Ensembl ID : ENSEEUG00000000887
Gene Symbol: RXRA
1 External references
249 Possible Orthologues:

Retinoid X Receptor Beta

Ensembl ID : ENSEEUG00000012064
Gene Symbol: RXRB
1 External references
215 Possible Orthologues:

Ribosomal Protein L10

Ensembl ID : ENSEEUG00000002938
Gene Symbol: RPL10
1 External references
119 Possible Orthologues:

Ribosomal Protein L13a

Ensembl ID : ENSEEUG00000014071
Gene Symbol: RPL13A
1 External references
233 Possible Orthologues:

Ribosomal Protein L15

Ensembl ID : ENSEEUG00000011286
Gene Symbol: RPL15
1 External references
204 Possible Orthologues:

Ribosomal Protein L18

Ensembl ID : ENSEEUG00000015872
Gene Symbol: RPL18
1 External references
276 Possible Orthologues:

Ribosomal Protein L23

Ensembl ID : ENSEEUG00000014766
Gene Symbol: RPL23
1 External references
207 Possible Orthologues:

Ribosomal Protein L24

Ensembl ID : ENSEEUG00000009320
Gene Symbol: RPL24
4 External references
236 Possible Orthologues:

Ribosomal Protein L30

Ensembl ID : ENSEEUG00000000964
Gene Symbol: RPL30
4 External references
239 Possible Orthologues:

Ribosomal Protein L34

Ensembl ID : ENSEEUG00000010390
Gene Symbol: RPL34
4 External references
272 Possible Orthologues:

Ribosomal Protein L35

Ensembl ID : ENSEEUG00000012696
Gene Symbol: RPL35
1 External references
315 Possible Orthologues:

Ribosomal Protein L39

Ensembl ID : ENSEEUG00000004227
Gene Symbol: RPL39
3 External references
176 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).